| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.
BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 919.9K | - | - | |
| CEO | 497.0K | $34.30M | - | |
| CFO | 336.5K | $26.88M | - | |
| Other | 122.7K | $9.80M | - | |
| Dir | 120.8K | $10.15M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 4, 2020 | Stephenson Brian C | See Remarks | Sell | 8,694 | $29.37 | $255,301.53 | -2.6% | |
| May 4, 2020 | Kumar Neil | CEO And President | Sell | 80,400 | $29.40 | $2,364,085.00 | -3.1% | |
| Apr 27, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,000 | $32.01 | $64,027.60 | -16.9% | |
| Apr 8, 2020 | Turtle Cameron | See Remarks | Sale+OE | 8,000 | $27.04 | $216,357.60 | -44.9% | |
| Apr 7, 2020 | Kumar Neil | CEO And President | Sell | 1,805 | $25.48 | $45,983.10 | - | |
| Apr 3, 2020 | Kumar Neil | CEO And President | Sell | 300 | $25.09 | $7,528.00 | - | |
| Apr 2, 2020 | Kumar Neil | CEO And President | Sell | 77,895 | $26.02 | $2,026,465.64 | -2.9% | |
| Apr 1, 2020 | Henderson Michael Thomas57 | See Remarks | Sell | 2,585 | $26.94 | $69,629.23 | -1.5% | |
| Apr 1, 2020 | Stephenson Brian C | See Remarks | Sell | 7,200 | $26.61 | $191,609.57 | -2.1% | |
| Mar 3, 2020 | Kumar Neil | CEO And President | Sell | 120,000 | $32.28 | $3,874,030.43 | -4.3% |